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http://dx.doi.org/10.1016/j.jds.2012.1Abstract Thymomas with immunodeficiency (formerly Good’s syndrome) are a rare acquired
disease of combined T- and B-cell immunodeficiency accompanying a thymoma. Recurrent
opportunistic infections associated with disorders of both humoral and cell-mediated immunity
frequently accompany this rare primary, adult-onset immunodeficiency. This is a report of
a case of a thymoma with immunodeficiency in a 65-year-old male patient who developed
recurrent oral herpetic infections. He consulted us about recurrent vesiculo-ulcerative lesions
on his tongue, lower lip, and buccal mucosa. Results of laboratory examinations indicated hy-
pogammaglobulinemia accompanied by diminished B cells in the peripheral blood, which is
consistent with the characteristic features of a thymoma with immunodeficiency. After a diag-
nosis confirming herpes simplex virus infection, systemic antiviral therapy was administered,
which was effective for his vesiculo-ulcerative lesions at follow-up. When an intractable infec-
tion accompanied by a thymoma is encountered, increased awareness about the clinical and
immunological profiles of this primary immunodeficiency may help in its early diagnosis,
thereby preventing mortality.
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0.005Although thymomas are the most frequently encountered
primary neoplasm in the anterior mediastinum in adult
patients, they are actually rare malignant neoplasms.1
Immunodeficiency syndrome associated with a thymoma
was first reported by Good and colleagues in 1954 and wasublic of China. Publishedby ElsevierTaiwanLLC. This is anopenaccess
ses/by-nc-nd/4.0/).
104 Y.S. Aydintug et alcommonly referred to as Good’s syndrome.2 However, the
current classification (2007) of the International Union of
Immunological Societies replaced this old eponym with
“thymoma with immunodeficiency” and lists it is a primary
immunodeficiency.2
This syndrome is a rare acquired disease of combined T-
and B-cell immunodeficiency accompanying a thymoma and
has an incidence rate of approximately 6e11% in thymoma
cases.3 The affected patients are most commonly between
40 and 70 years of age and have a thymoma, fewer or no B
cells in the peripheral blood, hypogammaglobulinemia,
inversion of the CD4-to-CD8 ratio, and defects in cell-
mediated immunity.1,4 Patients with this primary immuno-
deficiency are at increased risk of developing severe
opportunistic infections including herpes simplex virus
(HSV)-related infections.2
HSV infections represent one of the most widespread
infections of the orofacial region. HSV type 1 and type 2
(HSV-1 and HSV-2) are two strains of the herpes virus family,
the Herpesviridae, which infect humans. These two viruses
can infect the mouth or genitals; generally, HSV-1 is
considered to infect the regions “above the waist”, while
HSV-2 is considered to infect the region “below the waist”.
Although most of the primary orofacial HSV infections are
caused by HSV-1, infection by HSV-2 is increasingly
common.5 A primary HSV-1 infection in oral and perioral
sites usually manifests as gingivostomatitis, whereas reac-
tivation of the virus in the trigeminal sensory ganglion gives
rise to mild cutaneous and mucocutaneous disease, which is
often termed as recurrent herpes labialis. However,
recurrent HSV-1 infection in the mouth is less common than
herpes labialis and is unusual in otherwise healthy persons.6
In immunocompromised patients, recurrent oral HSV
infections are described as “atypical” and the lesions are
more extensive and aggressive, slow or nonhealing, and
extremely painful.7 Recurrent herpetic infections of the
tongue are exceptional and are only encountered in
patients with immunodeficiency.8
Herein, we report a case of a thymoma with immuno-
deficiency in a patient who developed excessive recurrent
oral herpetic infections.Case presentation
In October 2009, a 65-year-old man consulted us because he
had been suffering from recurrent vesiculo-ulcerativeFigure 1 (A) Discrete erosive lesion covered by a yellowish-whit
lower lip labial mucosa; (B) appearance of the right buccal mucos
thickened yellowish-white plaques and nodules on the dorsal tonglesions of his tongue, lower lip, and buccal mucosa for
approximately 4 years; he had been treated for a clinical
diagnosis of lichen planus and fungal infection. He had
a history of a thymoma first identified by a computed
tomography scan after a traffic accident in 2003 and of an
extended thymectomy for the thymoma removal in March
2007. Results of a histopathological analysis revealed “type
AB medullary thymoma” (according to the Masaoka system
of staging, the tumor was at stage II due to microscopic
invasion into the capsule). His medical history also showed
that he had received adjuvant (preventive) radiation
therapy as a microscopic monitoring of the invasion
[5000 cGy in 25 sessions (1 session Z 200 cGy administra-
tion)] in June 2007 and was treated for a prolonged fever of
unknown origin with antibiotics and antipyretics in August
and September 2007. In addition, he reported chronic
diarrhea, which began about a year ago and is ongoing.
The patient was admitted to our hospital in October
2009. Upon admission, he had a discrete erosive lesion
covered by a yellowish-white fibrinous exudate with
surrounding mucosal erythema on the lower lip (Fig. 1A)
and buccal mucosa (Fig. 1B), and the well-demarcated,
indurated, and thickened yellowish-white plaques and
nodules on the dorsal tongue (Fig. 1C). Regional lymph-
adenopathy was present. Written consent was obtained
from the patient, and owing to the atypical clinical
presentation, a biopsy was performed under local anes-
thesia. An oral biopsy specimen was taken from the tongue.
A histological analysis revealed the following marked
hyperplastic changes in the mucosal epithelium: mainly
irregular acanthosis, parakeratosis, edema, and lympho-
cyte exocytosis (Fig. 2A). In addition, there were ulcerated
vesicles. Near the ulcerated areas, characteristic virus-
infected keratinocytes were observed along the basal
layer of the epithelium. They were large cells with
homogenous eosinophilic cytoplasm and mummified chro-
matin with a thick nuclear membrane. Multinucleation and
nuclear molding were frequent (Fig. 2B).
Blood samples were collected on the same day. Results
of a laboratory examination revealed the following: white
blood cell count, 4600/mm3; hemoglobin, 12.2 g/dL;
platelet count, 152,000/mm3; C-reactive protein, 10.6 mg/
L; total protein, 6.21 g/L; and albumin of 4.48 g/dL.
Laboratory data included the following: low immunoglob-
ulin G (IgG), 5.91 g/L (normal: 800e1600 mg/dL); IgA,
0.25 g/L (normal: 80e400 mg/dL); and IgM, 0.17 g/L
(normal: 50e180 mg/dL). A lymphocyte subset analysis ofe fibrinous exudate with surrounding mucosal erythema on the
a before treatment; and (C) well-demarcated, indurated, and
ue.
Figure 2 (A) Histological analysis revealed ulceration (black arrows) in the center of the sample due to a ruptured herpetic
bullous lesion, and surrounding oral mucosal epithelium showing hyperplastic changes characterized by irregular acanthosis and
parakeratosis (red arrows; hematoxylin and eosin (H&E), 40). (B) In zones surrounding the ulcerated area, keratinocytes with viral
cytopathic changes such as multinucleation, nuclear molding, and mummified chromatin (red arrow) can be seen (H&E, 200).
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The percentage of CD19þ B cells (0.1%) was found to be
lower than the normal range (7e23%). Although percent-
ages of CD3þ (60.7%; normal: 62.8e85.0%) and CD4þ T cells
(20.1%; normal: 34.0e63.8%) were low, the percentage of
CD8þ T cells (39.7%) was within the normal range (normal:
19e48%). As a result, a reduced CD4-to-CD8 ratio of 0.50
was found (normal: 0.67e3.11). Results of HIV1/2 serologic
screening were negative. With regard to the type-specific
HSV serologic screening, the HSV-1 IgG titer was 1.83
(normal: 0e1) sample/cutoff, and the HSV-2 IgG titer was
0.24 (normal: 0e1) sample/cutoff.
The final diagnosis was that of HSV-1 infection. Upon
diagnosis, oral systemic antiviral therapy (200 mg acyclovir
every 4 hours, 5 times daily) was administered for 10 days.
After 2 weeks, complete healing of the lesions on the lower
lip (Fig. 3A) and buccal mucosa (Fig. 3B) was observed, while
there was a partial healing of the lesion on the tongue
(Fig. 3C). Meanwhile, the patient consulted with the
Department of Immunology. Immunodeficiency due to a thy-
moma with immunodeficiency explained why the recurrent
oral HSV-1 infection had been intractable for several years.
Thus, prophylactic intravenous immunoglobulin (IVIG)
therapy and routine control of infections in the patient were
initiated by the Department of Immunology.
Discussion
In general, symptoms of Good’s syndrome caused by
humoral and cellular immunodeficiency are occasionallyFigure 3 (A and B) Complete healing of the lesions on the l
improvement in the lesion on the dorsal tongue was seen after trecomplicated by leukopenia. Infections are one of the main
characteristics of Good’s syndrome.9 The most commonly
documented infectious complications in patients with
a thymoma with immunodeficiency are recurrent upper and
lower respiratory tract infections with encapsulated
organisms.2,4 Patients with a thymoma with immunodefi-
ciency also have increased susceptibility to bacterial,
fungal, viral, and opportunistic infections related to both
humoral and cell-mediated immune deficiencies.4 These
infections may be severe or even fatal in patients with
a thymoma with immunodeficiency.2
An extended thymectomy, radiation therapy, or
chemotherapy are the available options for treating the
thymoma in combination with Ig replacement therapy to
maintain adequate IgG values to prevent opportunistic
infections.3 Unfortunately, there are no case reports of
a thymectomy resolving the immunodeficient state associ-
ated with a thymoma with immunodeficiency.3 Our patient
had suffered from oral recurrent HSV infections for 2 years
before the extended thymectomy. His thymoma with
immunodeficiency had been diagnosed at least 4 years
before the operation, and the thymectomy might not have
resolved the immunodeficiency as previously reported.3
The prognosis of patients with a thymoma with immu-
nodeficiency is thought to be worse than for those with
other immunodeficiencies.4 In contrast to a thymoma with
immunodeficiency, the common variable immunodefi-
ciency, which is also characterized by hypogammaglobu-
linemia, is associated with less frequent and less
severe cellular immunodeficiency and fewer opportunisticower lip and buccal mucosa was observed. (C) Remarkable
atment.
106 Y.S. Aydintug et alinfections including HSV infection. In addition, the clinical
presentation of HSV infection is usually atypical with
a thymoma with immunodeficiency.2 Immunological
investigations, including quantitative Ig levels, B cells, and
T-cell subsets, should be considered as a part of the
routine diagnostic evaluation in patients with a thymoma
and intractable infections. If immunologic test results are
normal, testing should be performed periodically if the
clinical suspicion of a thymoma with immunodeficiency
persists, because there can be an interval between the
diagnosis of immunodeficiency and/or a thymoma and
development of infection.4
In immunocompromised patients, atypical clinical
manifestations of HSV presenting as tumor-like nodules or
condylomatous or hypertrophic lesions, rather than
a classic ulcer may occur. Such unusual presentations
increase the risk of a misdiagnosis and delays in appro-
priate treatment.10 In this case report, we describe an
immunocompromised patient with an unusual tumoral
presentation of recurrent herpetic infections of the
tongue. The predominant histopathological finding was
marked hyperplastic changes with irregular acanthosis,
parakeratosis, edema, and lymphocyte exocytosis. It is
crucial to be aware of these unusual presentations to
provide an early, correct diagnosis and effective treatment
for HSV.
In immunocompromised groups, oral acyclovir seems to
be the drug of choice for recurrent HSV-1 infections, but
recently famciclovir was found to be effective and has
the convenience of less frequent dosing than acyclovir.6
Topical treatment for these patients is usually of little
clinical benefit.6 In our case, after the HSV infection was
confirmed by histopathological, clinical, and laboratory
examinations, considerable improvement with acyclovir
therapy was seen in the intractable lesions. Furthermore,
it was reported that IVIG substitution is indicated in all
patients with a thymoma with immunodeficiency, as it
may be associated with improved control of infections,
decreased use of antibiotics, reduced hospitalizations, and
perhaps improved survival in patients with a thymoma withimmunodeficiency and other hypogammaglobulinemic
conditions.2 For this reason, the patient was directed to the
Department of Immunology for IVIG therapy and initiation
of routine controls.
In conclusion, when an intractable infection accompa-
nied by a thymoma is encountered, increased awareness
about clinical and immunological profiles of this primary
immunodeficiency may increase early diagnosis of this
condition and prevent mortality.
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